Comparison the Anti-atherogenic and hypolipidaemic effect of Cod liver oil, pomegranate seed oil and Rosuvastatin in hyperecholestrolemic rats
DOI:
https://doi.org/10.59658/jkas.v4i5.696Abstract
Rosuvastatin known is the more "statin moderating the lipid profile by reduction the low density-lipoprotein than the other statin such as atorvastatin, simvastatin and parvostatin". The present study was designed to investigate the anti-atherogenic and the hypolipidemic effect of cod liver oil, pomegranate seed oil and rosuvastatin in hypercholesterolemic rats. Thirty five albino wister rats were divided randomly into five equal groups, the first group served as negative control, all rats were administrated normal saline. The second group as positive control were rats administrated high cholesterol diet for six weeks. The animals in the third, fourth and fifth groups were administrated for 6 weeks as fallow: cod liver oil ( 0.5 mg/kg rat per day), pomegranate seed oil (200 mg/kg/day) and rosuvastatin (0.5 mg/kg/day, orally), respectively; In addition high cholesterol diet. The result revealed the high cholesterol diet in the positive control group caused a significant (p≤0.05) alteration in the lipid profile by increasing the serum total cholesterol (TC), Low density lipoprotein(LDL-c), very low density lipoprotein (VLDL-c) and triglyceride (TGs) as well as significant (p≤0.05) decrease the High-density lipoprotein. Also, the result showed a significant (p≤0.05) increase atherogenic indices by increase the coronary risk index (TC/HDL-C), atherogenic Coefficient (TC-HDL-C/HDL-C) and Atherogenic index of serum Log(TG/HDL-C) compare with negative control group. Indicated results significant (p>0.05) decrease in the level of serum glutathione (GSH) and significant (p≤0.05) increase in the level of malondialdehyde (MDA). While the animals in the group 3,4 and 5 were administrated CLO, PSO and statin the result clarified a significant (p≤0.05) improvement in studied parameters , through decrease the TC, LDL-C, VLDL-C, TG, MDA and atherogenic indices" , and increase the HDL-C and GSH compared with negative and positive control groups.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Copyright (c) 2024 is the Author's article. Published by the Journal of Kerbala for Agricultural Sciences under a CC BY 4.0 license
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing Terms
All articles are published under a Creative Commons License and will be directed to the Creative Commons Attribution 4.0 International License (CC BY 4.0) That permits use, distribution, and reproduction in any medium, provided the original work is properly cited. This license also allows the work to be used for commercial purposes.
Use by both non-commercial and commercial users
This content is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, permitting use by both non-commercial and commercial users. Individual users may access, download, copy, display, and redistribute the articles to colleagues, as well as adapt, translate, and text- and data-mine the content, subject to the following conditions:
- The author's moral rights, including the right of attribution and the right to protect their work from derogatory treatment, are respected.
- Where content in the article is identified as belonging to a third party, users must ensure that any reuse complies with the copyright policies of the owner of that content.
- If the article content is reused for research or educational purposes, users should maintain a link to the appropriate bibliographic citation, including the DOI and a link to the published version on the journal's website.
